Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

Oncolym makes progress in phase II

June 18, 1998

P&U identifies potent distamycin derivatives with improved therapeutic indices

June 18, 1998

New dihydrofolate reductase inhibitors with antitumor and antiparasitic activities

June 17, 1998

Yissum discloses peptidomimetic protein farnesyltransferase inhibitors

June 17, 1998

Results from antiangiogenic cancer gene therapy reported

June 16, 1998

Taisho presents the topoisomerase II inhibitor NCA-0424

June 16, 1998

Tricyclic compounds inhibiting abnormal cell growth discovered at Schering-Plough

June 16, 1998

Targeted Genetics' E1A gene therapy downregulates HER-2/neu oncogene in phase I

June 16, 1998

Vertex makes cancer drug available for licensing

June 16, 1998

AVI Biopharma offers oncology products for licensing

June 16, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...